Adalvo Acquires Enzene’s Romiplostim Biosimilar Programme
Adalvo has acquired a romiplostim biosimilar programme from Indian biotechnology company Enzene Biosciences,…
Trending
- Adalvo Acquires Enzene’s Romiplostim Biosimilar Programme
- Appian and PSI CRO Partner to Bring AI Into Clinical Trials
- Pfizer Partners With Edison Scientific to Accelerate AI-Driven Drug Research
- Dren Bio Raises $350M to Advance Experimental Blood Cancer Drug
- Glenmark Opens Major US Pharmaceutical Distribution Center in Pennsylvania
- Formation Bio Launches $600M Fund to Accelerate Drug Development
- Enthorin Licenses Fragile X Drug Candidate ENT-7340 to Rumi
- Lilly’s Retatrutide Shows Greater A1C Reduction in Type 2 Diabetes Trial
- Twist Bioscience Launches Faster Antibody Screening Technology
- Pathos AI Partners with BMS and Tempus to Advance Alzheimer’s Drug Research
Top Headlines
Appian and PSI CRO Partner to Bring AI Into Clinical Trials
Appian and PSI CRO have formed a strategic partnership to use artificial intelligence (AI) and automation to…
Pfizer Partners With Edison Scientific to Accelerate AI-Driven Drug Research
Pfizer has entered into an agreement with Edison Scientific to use artificial intelligence (AI) to accelerate drug…
Dren Bio Raises $350M to Advance Experimental Blood Cancer Drug
Dren Bio has raised $350 million in an oversubscribed private financing round to advance its experimental drug…
Glenmark Opens Major US Pharmaceutical Distribution Center in Pennsylvania
Glenmark Pharmaceuticals has inaugurated a new distribution center in Allentown, Pennsylvania, marking an important…
Formation Bio Launches $600M Fund to Accelerate Drug Development
Formation Bio has launched a $600 million Drug Development Accelerator Fund to help promising drug candidates move…
Featured Event
Clinical Trials
EyePoint’s DURAVYU Fails Main Endpoint in Phase 3 Wet AMD Trial
EyePoint, Inc. (NASDAQ: EYPT) has announced topline results from its LUCIA Phase 3 clinical trial evaluating DURAVYU (vorolanib intravitreal insert)…
Roche Wins FDA Approval for Enspryng in Thyroid Eye Disease
Roche has received approval from the U.S. Food and Drug Administration (FDA) for Enspryng (satralizumab) to treat adults with thyroid eye disease…
Wainua Misses Primary Endpoint in ATTR-CM Phase III Trial
AstraZeneca and Ionis Pharmaceuticals have announced that their Phase III CARDIO-TTRansform trial evaluating Wainua (eplontersen) in patients with…
Boehringer Advances Phase III Cancer Precision Medicine Trials
Boehringer Ingelheim has announced the launch of three Phase III clinical trials aimed at advancing precision oncology for patients with some of the…
uniQure Reports Early Promise for Epilepsy Gene Therapy
uniQure has reported encouraging early clinical results from its experimental gene therapy AMT-260, offering new hope for patients living with…
Massive Bio, Optellum Partner to Advance Lung Cancer Trial Access
Massive Bio and Optellum have announced a strategic collaboration designed to connect early lung cancer detection with faster access to clinical…
Fast shipping, security and absolute privacy is our main goal Viagra-Buy.com/ savings on their medication from a licensed and certified pharmacy.
The best pharmacy in america Viagra-Buy.com Fast delivery, best prices and for real men
Appian and PSI CRO Partner to Bring AI Into Clinical Trials
Appian and PSI CRO have formed a strategic partnership to use artificial intelligence (AI) and automation to…
Pathos AI Partners with BMS and Tempus to Advance Alzheimer’s Drug Research
Pathos AI has announced strategic collaborations with Bristol Myers Squibb (BMS) and Tempus AI to use artificial…
Drug Research
Big Pharma Turns to AI to Find New Drugs
Big pharma is investing in AI drug discovery through major partnerships with biotech and technology companies,…
AstraZeneca Invests $2B in Summit Therapeutics for Cancer Research
AstraZeneca has agreed to invest $2 billion in Summit Therapeutics to support the development of ivonescimab and…
Sentynl, Mereo Partner to Advance Oral AATD Lung Disease Therapy
Sentynl Therapeutics, a U.S.-based biopharmaceutical company and wholly owned subsidiary of Zydus Lifesciences, has…
Latus Bio Raises $97 Million to Advance Gene Therapies
Latus Bio, Inc. has secured $97 million in Series A financing to accelerate the development of its gene therapy…
UK Streamlines Drug Approvals to Accelerate Patient Access
The Medicines and Healthcare products Regulatory Agency (MHRA) and National Institute for Health and Care…
Manufacturing
SK pharmteco Invests $200M to Expand U.S. Drug Manufacturing
SK pharmteco has announced a five-year investment of more than $200 million to expand and upgrade its development…
Varda Raises $251M to Scale Space-Based Pharmaceutical Manufacturing
Varda Space Industries has raised $251 million in a Series D financing round to expand its work in space-based…
Genentech Plans $750 Million Device Manufacturing Facility in Oregon
Genentech, a member of the Roche Group, plans to invest approximately $750 million to build a new device…
Fujifilm and Taiho Partner on Next-Generation ADC Manufacturing
FUJIFILM Corporation and Taiho Pharmaceutical have formed a strategic partnership to advance manufacturing…
Cellares and SonomaBio Partner on Automated Treg Cell Therapy Manufacturing
Cellares and Sonoma Biotherapeutics have announced a new collaboration to automate the manufacturing of…
Cellares, TScan Partner on Automated TSC-101 Manufacturing
Cellares and TScan Therapeutics have entered into a strategic agreement to evaluate automated clinical…
Fujifilm Expands Stem Cell Manufacturing in Wisconsin
FUJIFILM Cellular Dynamics has inaugurated a new headquarters and induced pluripotent stem cell (iPSC) development…
Piramal, Ajinomoto Partner to Advance ADC Manufacturing Capabilities
Piramal Pharma Solutions and Ajinomoto Bio-Pharma Services have announced a strategic collaboration aimed at…
Diseases
Estuary Biotherapeutics Launches with $103 Million for Kidney Gene Therapies
Estuary Biotherapeutics has launched with $103 million in committed financing to develop targeted gene therapies…
Tenaya and Alnylam Partner to Discover New Genetic Targets for Heart Disease
Clinical-stage biotechnology company Tenaya Therapeutics has announced a new research collaboration with RNA…
AstraZeneca, CSPC Partner on Next-Generation Obesity Therapies
AstraZeneca has strengthened its weight management and metabolic disease pipeline through a new strategic…
China Approves ENHERTU for Second-Line HER2-Positive Gastric Cancer
China’s National Medical Products Administration (NMPA) has approved ENHERTU® (trastuzumab deruxtecan) for the…
InterAx, Alveus Partner to Advance Next-Generation Obesity Therapy
InterAx Biotech Ltd and Alveus Therapeutics Inc. have entered into a strategic research collaboration and licensing…
Sandoz to Acquire Just-Evotec Biologics Facility in Toulouse Under New Term Sheet
Sandoz has signed a non-binding term sheet with Evotec SE to potentially acquire Just–Evotec Biologics EU SAS,…
